Antihyperlipidemic activity of Chloroxylon swietenia in triton WR1339 induced hyperlipidemia


  • B. H. M. R. K. Guptha Department of Pharmacology, IQ City Medical College, Durgapur, West Bengal, India
  • S. L. D. V. Ramana Murty Kadali Department of Pharmacology, Modern Institute of Medical Sciences, Indore, Madhya Pradesh, India
  • Vijay Kumar M. Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences of Nitte University, Mangalore, India
  • Revanasiddappa B. C. Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences of Nitte University, Mangalore, India



Chloroxylon swietenia, Hyperlipidemia, Triton WR 1339


Background: Medicinal herbs are beneficial and effective either in the management and prevention of several metabolic disorders, associated with hyperlipidemia, hypertension and insulin resistance which increases the cardio-metabolic risk and demands for the life time therapy. Current allopathic medicines are expensive and reported with several adverse effects and hence, finding of a suitable herbal medicine for hyperlipidemic disorders is very important.

Methods: Thirty albino rats weighing 200-230g were randomly divided into 5 groups were rendered hyperlipidemia with a single dose of triton WR 1339. Normal control, positive control, standard, aqueous and ethanolic extract groups were treated with tween-80, tween-80, atorvastatin, aqueous and ethanolic extracts of Chloroxylon swietenia respectively for seven days. At the end of the study, blood was collected for estimation of the lipid profile.

Results: Both the aqueous and ethanolic extract groups significantly reduced the TG and VLDL levels.

Conclusions: The extracts exhibited remarkable activity on one or either parameter of the lipid profile. It could be due to the presence of alkaloids, steroids, flavonoids, coumarins and phenols in the extracts.


Shattat GF. A Review Article on Hyperlipidemia: Types, Treatments and New Drug Targets. Biomed Pharmacol J. 2014;7(2):399-409.

Aslesh OP, Jayasree AK, Karunakaran U, Venugopalan AK, Divakaran B, Mayamol TR, et al. Prevalence of hypercholesterolemia among adults aged over 30 years in a rural area of north Kerala, India: a cross-sectional study. WHO South-East Asia J Public Health. 2016;5(1):70-5.

Rosini TC, Silva AS, Moraes CD. Diet-induced obesity: rodent model for the study of obesity-related disorders. Revista da Associacao Medica Brasileira. 2012 Jun;58(3):383-7.

Thirumalai T, Tamilselvan N, David E. Hypolipidemic activity of Piper betel in high fat diet induced hyperlipidemic rat. Journal of Acute Disease. 2014 Jan 1;3(2):131-5.

Matos SL, Paula HD, Pedrosa ML, Santos RC, Oliveira EL, Chianca Júnior DA, Silva ME. Dietary models for inducing hypercholesterolemia in rats. Brazilian Archives of Biology and Technology. 2005 Mar;48(2):203-9.

Raj CD, Jayanthi V, Manaswini VS, Gayathri R, Ranjani C, Brindha P. Effect of polyherbal formulation (OB-6) on high fat diet induced hyperlipidemia in rats. International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4(2):31-5.

Girija K, Lakshman K. Anti-hyperlipidemic activity of methanol extracts of three plants of Amaranthus in triton-WR 1339 induced hyperlipidemic rats. Asian Pacific Journal of Tropical Biomedicine. 2011 Sep 1;1(1):S62-5.

Pasha SR. Evaluation of hypolipidemic activity of methanolic extract of ficus dalhousiaemiq. on triton-x and high fat diet induced hyperlipidemia in albino rats EJPMR. 2014;1(1):183-91.

Mishra R, Pandit K, Bhagwat AM, Brijesh S. Antihyperlipidemic activity of alcoholic extracts of trichosanthes anguina in triton WR 1339 induced hyperlipidemic rats. IJPSR. 2014;5(10):4269-74.

Tripathi KD. Hypolipidaemic drugs and plasma expanders. Essentials of Medical Pharmacology. 7th ed. New Delhi, Jaypee Brothers Medical Publishers (P) Ltd; Chapter 45; 2015:634-646.

Kumar K, Ganesh M, Baskar S, Srinivasan K, Kanagasabai R, Sambathkumar R, et al. Evaluation of Anti-inflammatory activity and toxicity studies of Chloroxylon swietenia in Rats. Anc Sci Life. 2006;3:33-43.

Prabakaran R, Arivoli S, Hema A, Kamatchi C. Isolation and characterization of flavonoids from Chloroxylon swietenia. J Chem Pharm Res. 2011;3(3):805-13.

Ramadevi D. Antimicrobial activity on leaf extract of Chloroxylon swietenia. JGTPS. 2014;5(3):1940-42.

Harwansh RK, Pareta SK, Patra KC, Jangde R. Screening of Chloroxylon swietenia dc root for antibacterial and anthelmintic activities. Pharmacologyonline. 2011;1:544-52.

Pingale R, Dash GK. A Review on Ethnopharmacology, Phytochemistry and Bioactivity of Chloroxylon swietenia DC International Journal of Emerging Trends in Pharmaceutical Sciences. 2013;1(1):11-20.

Nayak JB. Comparative study of Chloroxylon swietenia leaf and bark against Culex quinque fasciatus mosquito larvae. International Journal of Multidisciplinary Research and Development. 2014;1(1):69-71.

Kiran SR, Bhavani K, Devi PS, Rao BR, Reddy KJ. Composition and larvicidal activity of leaves and stem essential oils of Chloroxylon swietenia DC against Aedes aegypti and Anopheles stephensi. Bioresource technology. 2006 Dec 1;97(18):2481-4.

Ravi Kiran S, Pillay VS, Reddy JK. Studies on mosquito larvicidal activity of Chloroxylon swietenia dc. Journal of pharmacognosy. 2012; 3(2):123-25.

Kadali RMSLDV, Das MC, Vijayaraghavan R, Shanmukha I. In vitro evaluation of antidiabetic activity of aqueous and ethanolic leaves extracts of Chloroxylon swietenia. Natl J Physiol Pharm Pharmacol. 2017;7(5):486-90.

Kadali RMSLDV, Das MC, Vijayaraghavan R, Vijay Kumar M. Evaluation of antidiabetic activity of aqueous and ethanolic leaf extracts of Chloroxylon swietenia in streptozotocin-induced diabetes in albino rats. Biomedical Pharmacology Journal. 2017;10(3):1347-53.

Pankti PD, Pragnesh VP. Anti hyperlipidemic activity of Tephrosia purpurea plant extracts in poloxomer 407 induced hyperlipidemic rats, Int Pharmacol Res. 2014;4(4):186-93.

Kumar G, Srivastava A, Sharma SK, Gupta YK. The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: a comparison with fenofibrate. Journal of Ayurveda and integrative medicine. 2013 Jul;4(3):165.

Ibrahim AY, Hendawy SF, Elsayed AA, Omer EA. Evaluation of hypolipidemic Marrubium vulgare effect in Triton WR-1339-induced hyperlipidemia in mice. Asian Pacific journal of tropical medicine. 2016 May 1;9(5):453-9.

Venkadeswaran K, Muralidharan AR, Annadurai T, Ruban VV, Sundararajan M, Anandhi R, et al. Antihypercholesterolemic and antioxidative potential of an extract of the plant, Piper betle, and its active constituent, eugenol, in triton WR-1339-Induced hypercholesterolemia in experimental rats. Evidence-Based Complementary and Alternative Medicine. 2014;2014. Available at:

Pareek A, Chandurkar N, Tenpe CR, Yeole PG, Payghan R. Effect of Atorvastatin and Hydroxychloroquine Combination on Triton WR 1339 Induced Hyperlipidemia in Rats. Inventi Impact: Molecular Pharmacology. 2010;1(3).

Robert MW, Thomas BP. Drug Therapy for Hypercholesterolemia and Dyslipidemia. In: Laurence LB, Bruce AC eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th Ed. New York, McGraw-Hill; Chapter 31; 2006:948-953.

Shabnam N, Mohammad K, Majid KR, Maryam Abrishami, Mohammadreza J, Gholamhasan K, et al. Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240.

Omotayo OE, Ndubuisi NN, Joseph LA, Ugochi AO, Chinonyelum TE, Basil C, et al. Nigerian Honey Ameliorates Hyperglycemia and Dyslipidemia in Alloxan-Induced Diabetic Rats. Nutrients. 2016;8(3):95.




How to Cite

Guptha, B. H. M. R. K., Murty Kadali, S. L. D. V. R., M., V. K., & B. C., R. (2018). Antihyperlipidemic activity of Chloroxylon swietenia in triton WR1339 induced hyperlipidemia. International Journal of Basic & Clinical Pharmacology, 7(3), 518–523.



Original Research Articles